CompaniesByCap
GKOS
Glaukos Corporation (GKOS)
NYSE · Healthcare

Glaukos Corporation Revenue 2013–2025

Glaukos Corporation annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Glaukos Corporation revenue for the quarter ending March 31, 2026 was 150.6 M, a 41.16% increase year-over-year.
  • Glaukos Corporation revenue for the twelve months ending March 31, 2026 was 514.9 M, a 44.62% increase year-over-year.
  • Glaukos Corporation annual revenue for 2025 was 507.4 M, a 32.33% increase from 2024.
  • Glaukos Corporation annual revenue for 2024 was 383.5 M, a 21.85% increase from 2023.
  • Glaukos Corporation annual revenue for 2023 was 314.7 M, a 11.26% increase from 2022.
  • Glaukos Corporation annual revenue for 2022 was 282.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Glaukos Corporation (GKOS) — Frequently Asked Questions

Glaukos Corporation (GKOS) is a publicly traded US company. It has a market capitalization of $7.11B. In fiscal 2025 it reported revenue of $507M and net income of -$188M. Explore GKOS's stock price, financial statements, earnings history, margins and key ratios below.

What is Glaukos Corporation's market cap?

Glaukos Corporation (GKOS) has a market capitalization of $7.11B.

What is the GKOS stock price?

GKOS trades at $124.26 (+1.45% on the day).

How much revenue does Glaukos Corporation make?

Glaukos Corporation reported revenue of $507M in fiscal 2025.

Is GKOS profitable?

In fiscal 2025, Glaukos Corporation reported net income of -$188M.